In this issue:
Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance
SBRT + abiraterone acetate for oligometastatic CRPC
A novel nomogram to predict the probability of PLN metastases
Digital rectal examination screening for prostate cancer
18F-PSMA-1007 PET/CT and multiparametric MRI
Recurrence after metastasis-directed therapy in oligorecurrent prostate cancer
Patient- vs clinician-reported outcomes of incontinence and ED
Multiparametric MRI and MRI-targeted biopsy in radiorecurrent prostate cancer
Local treatment-related adverse effects in advanced prostate cancer
Biweekly vs triweekly cabazitaxel in older patients with mCRPC
Please login below to download this issue (PDF)